Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study-Reference-Cited by-同舟云学术

Implementation and outcomes of dolutegravir-based first-line antiretroviral therapy for people with HIV in South Africa: a retrospective cohort study

Published:2023-05 Issue:5 Volume:10 Page:e284-e294
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Dorward Jienchi,Sookrajh Yukteshwar,Khubone Thokozani,van der Molen Johan,Govender Riona,Phakathi Sifiso,Lewis Lara,Bottomley Christian,Maraj Munthra,Lessells Richard J,Naidoo Kogieleum,Butler Christopher C,Van Heerden Rose,Garrett Nigel

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference32 articles.

1. End resistance to dolutegravir roll-out;Lancet HIV,2020

2. Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research;Dorward;Lancet HIV,2018

3. Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: a systematic literature review and network meta-analysis;Kanters;EClinicalMedicine,2020

4. Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines;Phillips;Lancet HIV,2020

5. Community and activists demand for tenofovir/emtricitabine or lamivudine/dolutegravir and routine viral load testing;Baptiste;Curr Opin HIV AIDS,2019

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three Year Outcomes after Programmatic Transitioning to Dolutegravir in the Context of Severe Civil Unrest in Haiti;2024-08-14

2. The long wait for long-acting HIV prevention and treatment formulations;The Lancet HIV;2024-08

3. HIV Drug Resistance in Newly Diagnosed Young Children in the Western Cape, South Africa;Pediatric Infectious Disease Journal;2024-07-23

4. Predicting emergent Dolutegravir resistance in South Africa: A modelling study;2024-07-21

5. Measuring the health-related quality of life in HIV patients with integrase strand transfer inhibitor-based regimens in China;2024-07-18